APA

Prins R. C., Rademacher B. L., Mongoue-Tchokote S., Alumkal J. J., Graff J. N., Eilers K. M. & Beer T. M. (20120508). C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results. : Urologic oncology.

Chicago

Prins Renee C, Rademacher Brooks L, Mongoue-Tchokote Solange, Alumkal Joshi J, Graff Julie N, Eilers Kristine M and Beer Tomasz M. 20120508. C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results. : Urologic oncology.

Harvard

Prins R. C., Rademacher B. L., Mongoue-Tchokote S., Alumkal J. J., Graff J. N., Eilers K. M. and Beer T. M. (20120508). C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results. : Urologic oncology.

MLA

Prins Renee C, Rademacher Brooks L, Mongoue-Tchokote Solange, Alumkal Joshi J, Graff Julie N, Eilers Kristine M and Beer Tomasz M. C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results. : Urologic oncology. 20120508.